About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Cannabidiol Treatment in Patients With Early Psychosis

NCT02504151·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Yale University

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Male or female
Primary psychotic disorder
Ages 18-65 (inclusive)

You may not be if

Current significant medical condition or other comorbidities
Current substance depdendence
Women who are pregnant or breastfeeding

The record

StatusCompleted

PhasePhase 2

Taking part18

StartedJan 2016

UpdatedSep 6, 2022

Conditions

Schizophrenia Schizoaffective Disorder

Where2

Connecticut Mental Health Center
New Haven, Connecticut, United States
VA Connecticut Healthcare System
West Haven, Connecticut, United States

Clareo Health | Cannabidiol Treatment in Patients With Early Psychosis